Stockreport

Review Of The Developmental Landscape Of Long-Acting Anti-VEGF Therapies In Wet-AMD [Seeking Alpha]

EyePoint Pharmaceuticals, Inc.  (EYPT) 
Last eyepoint pharmaceuticals, inc. earnings: 3/5 07:00 am Check Earnings Report
PDF Current treatment for wet AMD involves frequent anti-VEGF injections, but there is a need for therapies with less frequent injections that can maintain vision. Severa [Read more]